 | • レポートコード：C-GIR20G2776 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「炎症性腸疾患治療の世界市場2019年」は、グローバルにおける炎症性腸疾患治療市場を展望するレポートです。炎症性腸疾患治療のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・炎症性腸疾患治療の市場概観 ・炎症性腸疾患治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・炎症性腸疾患治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・炎症性腸疾患治療の世界市場規模 ・炎症性腸疾患治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・炎症性腸疾患治療のアメリカ市場規模推移 ・炎症性腸疾患治療のカナダ市場規模推移 ・炎症性腸疾患治療のメキシコ市場規模推移 ・炎症性腸疾患治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・炎症性腸疾患治療のドイツ市場規模推移 ・炎症性腸疾患治療のイギリス市場規模推移 ・炎症性腸疾患治療のロシア市場規模推移 ・炎症性腸疾患治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・炎症性腸疾患治療の日本市場規模推移 ・炎症性腸疾患治療の中国市場規模推移 ・炎症性腸疾患治療の韓国市場規模推移 ・炎症性腸疾患治療のインド市場規模推移 ・炎症性腸疾患治療の東南アジア市場規模推移 ・炎症性腸疾患治療の南米市場分析（ブラジル、アルゼンチン等） ・炎症性腸疾患治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・炎症性腸疾患治療の種類別分析/販売量、売上、市場シェア（潰瘍性大腸炎、クローン病、その他） ・炎症性腸疾患治療の用途別分析/市場規模（病院、医学研究機関、その他） ・炎症性腸疾患治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・炎症性腸疾患治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Inflammatory Bowel Disease Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Inflammatory Bowel Disease Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Inflammatory Bowel Disease Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Inflammatory Bowel Disease Therapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
Cosmo Pharmaceuticals
Gilead Sciences
Abbott
AbbVie
Johnson & Johnson
Takeda Pharmaceutical Company
Innovate Biopharma
Celgene Corporation
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ulcerative Colitis
Crohns Disease
Others
Market Segment by Applications, can be divided into
Hospital
Medical Research Organization
Other
Table of Contents
1 Inflammatory Bowel Disease Therapy Market Overview
1.1 Product Overview and Scope of Inflammatory Bowel Disease Therapy
1.2 Classification of Inflammatory Bowel Disease Therapy by Types
1.2.1 Global Inflammatory Bowel Disease Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Types in 2018
1.2.3 Ulcerative Colitis
1.2.4 Crohns Disease
1.2.5 Others
1.3 Global Inflammatory Bowel Disease Therapy Market by Application
1.3.1 Global Inflammatory Bowel Disease Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Medical Research Organization
1.3.4 Other
1.4 Global Inflammatory Bowel Disease Therapy Market by Regions
1.4.1 Global Inflammatory Bowel Disease Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Inflammatory Bowel Disease Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Inflammatory Bowel Disease Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Inflammatory Bowel Disease Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Inflammatory Bowel Disease Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Inflammatory Bowel Disease Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Inflammatory Bowel Disease Therapy (2014-2024)
2 Company Profiles
2.1 Cosmo Pharmaceuticals
2.1.1 Business Overview
2.1.2 Inflammatory Bowel Disease Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Gilead Sciences
2.2.1 Business Overview
2.2.2 Inflammatory Bowel Disease Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Gilead Sciences Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Abbott
2.3.1 Business Overview
2.3.2 Inflammatory Bowel Disease Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 AbbVie
2.4.1 Business Overview
2.4.2 Inflammatory Bowel Disease Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AbbVie Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Johnson & Johnson
2.5.1 Business Overview
2.5.2 Inflammatory Bowel Disease Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Takeda Pharmaceutical Company
2.6.1 Business Overview
2.6.2 Inflammatory Bowel Disease Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Innovate Biopharma
2.7.1 Business Overview
2.7.2 Inflammatory Bowel Disease Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene Corporation
2.8.1 Business Overview
2.8.2 Inflammatory Bowel Disease Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corporation Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Inflammatory Bowel Disease Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Inflammatory Bowel Disease Therapy Market Competition, by Players
3.1 Global Inflammatory Bowel Disease Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Inflammatory Bowel Disease Therapy Players Market Share
3.2.2 Top 10 Inflammatory Bowel Disease Therapy Players Market Share
3.3 Market Competition Trend
4 Global Inflammatory Bowel Disease Therapy Market Size by Regions
4.1 Global Inflammatory Bowel Disease Therapy Revenue and Market Share by Regions
4.2 North America Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
5 North America Inflammatory Bowel Disease Therapy Revenue by Countries
5.1 North America Inflammatory Bowel Disease Therapy Revenue by Countries (2014-2019)
5.2 USA Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
6 Europe Inflammatory Bowel Disease Therapy Revenue by Countries
6.1 Europe Inflammatory Bowel Disease Therapy Revenue by Countries (2014-2019)
6.2 Germany Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
6.4 France Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Countries
7.1 Asia-Pacific Inflammatory Bowel Disease Therapy Revenue by Countries (2014-2019)
7.2 China Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
7.5 India Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
8 South America Inflammatory Bowel Disease Therapy Revenue by Countries
8.1 South America Inflammatory Bowel Disease Therapy Revenue by Countries (2014-2019)
8.2 Brazil Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Inflammatory Bowel Disease Therapy by Countries
9.1 Middle East and Africa Inflammatory Bowel Disease Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
10 Global Inflammatory Bowel Disease Therapy Market Segment by Type
10.1 Global Inflammatory Bowel Disease Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Inflammatory Bowel Disease Therapy Market Forecast by Type (2019-2024)
10.3 Ulcerative Colitis Revenue Growth Rate (2014-2024)
10.4 Crohns Disease Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Inflammatory Bowel Disease Therapy Market Segment by Application
11.1 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Application (2014-2019)
11.2 Inflammatory Bowel Disease Therapy Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Medical Research Organization Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2024)
12.1 Global Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2024)
12.2 Global Inflammatory Bowel Disease Therapy Market Forecast by Regions (2019-2024)
12.3 North America Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
12.6 South America Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Inflammatory Bowel Disease Therapy Picture
Table Product Specifications of Inflammatory Bowel Disease Therapy
Table Global Inflammatory Bowel Disease Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Inflammatory Bowel Disease Therapy Revenue Market Share by Types in 2018
Figure Ulcerative Colitis Picture
Figure Crohns Disease Picture
Figure Others Picture
Table Global Inflammatory Bowel Disease Therapy Revenue (Million USD) by Application (2014-2024)
Figure Inflammatory Bowel Disease Therapy Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Medical Research Organization Picture
Figure Other Picture
Table Global Market Inflammatory Bowel Disease Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Type and Applications
Table Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Inflammatory Bowel Disease Therapy Type and Applications
Table Gilead Sciences Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Inflammatory Bowel Disease Therapy Type and Applications
Table Abbott Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Inflammatory Bowel Disease Therapy Type and Applications
Table AbbVie Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Inflammatory Bowel Disease Therapy Type and Applications
Table Johnson & Johnson Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Type and Applications
Table Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Innovate Biopharma Basic Information, Manufacturing Base and Competitors
Table Innovate Biopharma Inflammatory Bowel Disease Therapy Type and Applications
Table Innovate Biopharma Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Inflammatory Bowel Disease Therapy Type and Applications
Table Celgene Corporation Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Inflammatory Bowel Disease Therapy Type and Applications
Table Pfizer Inflammatory Bowel Disease Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Inflammatory Bowel Disease Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Inflammatory Bowel Disease Therapy Revenue Share by Players (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Revenue Share by Players in 2017
Figure Global Inflammatory Bowel Disease Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Inflammatory Bowel Disease Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Inflammatory Bowel Disease Therapy Revenue Market Share in 2018
Figure Global Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Inflammatory Bowel Disease Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Inflammatory Bowel Disease Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Revenue Market Share by Regions in 2018
Figure North America Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure South America Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Table North America Inflammatory Bowel Disease Therapy Revenue by Countries (2014-2019)
Table North America Inflammatory Bowel Disease Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Inflammatory Bowel Disease Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Inflammatory Bowel Disease Therapy Revenue Market Share by Countries in 2018
Figure USA Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Table Europe Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Inflammatory Bowel Disease Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Inflammatory Bowel Disease Therapy Revenue Market Share by Countries in 2018
Figure Germany Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure UK Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure France Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy Revenue Market Share by Countries in 2018
Figure China Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure India Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Table South America Inflammatory Bowel Disease Therapy Revenue by Countries (2014-2019)
Table South America Inflammatory Bowel Disease Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Inflammatory Bowel Disease Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Inflammatory Bowel Disease Therapy Revenue Market Share by Countries in 2018
Figure Brazil Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Inflammatory Bowel Disease Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Inflammatory Bowel Disease Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Inflammatory Bowel Disease Therapy Revenue and Growth Rate (2014-2019)
Table Global Inflammatory Bowel Disease Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Inflammatory Bowel Disease Therapy Revenue Share by Type (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Revenue Share by Type (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Revenue Share by Type in 2018
Table Global Inflammatory Bowel Disease Therapy Revenue Forecast by Type (2019-2024)
Figure Global Inflammatory Bowel Disease Therapy Market Share Forecast by Type (2019-2024)
Figure Global Ulcerative Colitis Revenue Growth Rate (2014-2019)
Figure Global Crohns Disease Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Inflammatory Bowel Disease Therapy Revenue by Application (2014-2019)
Table Global Inflammatory Bowel Disease Therapy Revenue Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Revenue Share by Application (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Revenue Share by Application in 2018
Table Global Inflammatory Bowel Disease Therapy Revenue Forecast by Application (2019-2024)
Figure Global Inflammatory Bowel Disease Therapy Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Medical Research Organization Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Inflammatory Bowel Disease Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Inflammatory Bowel Disease Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Inflammatory Bowel Disease Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
Figure Europe Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
Figure South America Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Inflammatory Bowel Disease Therapy Revenue Market Forecast (2019-2024)
世界の珍炎症性疾患市場予測（～2024年） Scope of the Report: The global Rare Inflammatory Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…- 世界の消失性骨疾患治療市場予測（～2024年） Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…
- 世界の遺伝子治療市場予測（～2024年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…
- 世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…
- 世界の筋骨格障害幹細胞療法市場予測（～2024年） Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. This report studies on the Musculoskeletal Disorder Stem Cell Therapy. Scope of the Report: The global Musculoskeletal Disorder Stem Cell Therapy market is valued at xx million USD in 2018 and is expected to reach…